Maria A Ostos

Summary

Affiliation: Institut Pasteur
Country: France

Publications

  1. ncbi Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice
    M A Ostos
    Unité d Expression des Gènes Eucaryotes, Institut Pasteur, Paris, France
    Arterioscler Thromb Vasc Biol 21:1023-8. 2001
  2. ncbi Fructose intake increases hyperlipidemia and modifies apolipoprotein expression in apolipoprotein AI-CIII-AIV transgenic mice
    Maria A Ostos
    Unité d Expression des Gènes Eucaryotes, Institut Pasteur, Paris, France
    J Nutr 132:918-23. 2002
  3. ncbi Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide
    Delia Recalde
    Unité d Expression des Gènes Eucaryotes, Institut Pasteur, Paris, France
    Arterioscler Thromb Vasc Biol 24:756-61. 2004
  4. ncbi Expression and secretion of human apolipoprotein A-I in the heart
    Nadine Baroukh
    Unité d Expression des Gènes Eucaryotes, Institut Pasteur, Paris, France
    FEBS Lett 557:39-44. 2004
  5. ncbi Implication of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammation
    Maria A Ostos
    Unité d Expression des Gènes Eucaryotes, Institut Pasteur, Paris, France
    FEBS Lett 519:23-9. 2002
  6. ncbi Genetics and molecular biology
    Maria A Ostos
    Curr Opin Lipidol 13:219-21. 2002

Collaborators

Detail Information

Publications6

  1. ncbi Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice
    M A Ostos
    Unité d Expression des Gènes Eucaryotes, Institut Pasteur, Paris, France
    Arterioscler Thromb Vasc Biol 21:1023-8. 2001
    ..In addition, human apoA-IV accumulation was detected in the atherosclerotic lesions of apoA-IV/E(0) mice, suggesting that apoA-IV may inhibit oxidative damage to local tissues, thus decreasing the progression of atherosclerosis...
  2. ncbi Fructose intake increases hyperlipidemia and modifies apolipoprotein expression in apolipoprotein AI-CIII-AIV transgenic mice
    Maria A Ostos
    Unité d Expression des Gènes Eucaryotes, Institut Pasteur, Paris, France
    J Nutr 132:918-23. 2002
    ..Our data suggest that long-term fructose consumption had strong adverse effects in this hyperlipidemic mouse model...
  3. ncbi Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide
    Delia Recalde
    Unité d Expression des Gènes Eucaryotes, Institut Pasteur, Paris, France
    Arterioscler Thromb Vasc Biol 24:756-61. 2004
    ..Thus, we used h-apoA-IV/E(0) mice to determine whether h-apoA-IV plays a protective role after LPS administration...
  4. ncbi Expression and secretion of human apolipoprotein A-I in the heart
    Nadine Baroukh
    Unité d Expression des Gènes Eucaryotes, Institut Pasteur, Paris, France
    FEBS Lett 557:39-44. 2004
    ..From these novel findings, new insights into the role and function of apoA-I can be extrapolated...
  5. ncbi Implication of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammation
    Maria A Ostos
    Unité d Expression des Gènes Eucaryotes, Institut Pasteur, Paris, France
    FEBS Lett 519:23-9. 2002
    ..LPS-injected apoE-deficient mice appear to be an excellent animal model to analyze the implementation of new therapeutic approaches in the treatment of atherosclerosis by manipulating immunological effectors...
  6. ncbi Genetics and molecular biology
    Maria A Ostos
    Curr Opin Lipidol 13:219-21. 2002